VOR · Categories · Form 4

VOR - SEC Form 4 insider transactions

Vor Biopharma Inc. (VOR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for VOR

• 45d
  Director Ra Capital Management, L.P. sold $2,604,416 worth of shares (165,150 units at $15.77) (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 48d
  SEC Form 4 filed by Ra Capital Management, L.P.

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 54d
  SEC Form 4 filed by Ra Capital Management, L.P.

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 59d
  SEC Form 4 filed by Ra Capital Management, L.P.

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 63d
  SEC Form 4 filed by Ra Capital Management, L.P.

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 171d
  Director Ra Capital Management, L.P. gave a grant of 4,625,346 shares (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 171d
  SEC Form 4 filed by Director Joustra Wouter

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 171d
  SEC Form 4 filed by Director Levin Andrew David

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 182d
  SEC Form 4 filed by Chief Development Officer Zuraw Qing Che

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 182d
  CFO Mahatme Sandesh returned 694,137 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 182d
  SEC Form 4 filed by CEO and Chairman Kress Jean-Paul

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 221d
  Director Ra Capital Management, L.P. sold $10,368,938 worth of shares (400,408 units at $25.90) (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 224d
  Director Ra Capital Management, L.P. sold $6,204,863 worth of shares (221,166 units at $28.06) (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 229d
  Director Ra Capital Management, L.P. sold $3,433,992 worth of shares (117,050 units at $29.34) (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 230d
  Large owner Reprogrammed Interchange Llc sold $1,133,103 worth of shares (37,533 units at $30.19), decreasing direct ownership by 3% to 1,166,909 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 234d
  Large owner Reprogrammed Interchange Llc sold $2,348,744 worth of shares (73,676 units at $31.88), decreasing direct ownership by 6% to 1,204,442 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 234d
  Director Ra Capital Management, L.P. sold $13,707,361 worth of shares (464,025 units at $29.54) (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 236d
  Large owner Reprogrammed Interchange Llc sold $3,003,706 worth of shares (96,657 units at $31.08), decreasing direct ownership by 7% to 1,278,118 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 241d
  Large owner Reprogrammed Interchange Llc sold $4,116,369 worth of shares (124,146 units at $33.16), decreasing direct ownership by 8% to 1,374,775 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 243d
  Large owner Reprogrammed Interchange Llc sold $3,553,499 worth of shares (98,387 units at $36.12), decreasing direct ownership by 6% to 1,498,921 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 248d
  Large owner Reprogrammed Interchange Llc sold $1,646,237 worth of shares (41,752 units at $39.43), decreasing direct ownership by 3% to 1,597,308 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 259d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 263d
  Large owner Reprogrammed Interchange Llc sold $688,853 worth of shares (447,278 units at $1.54), decreasing direct ownership by 1% to 32,781,209 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 266d
  Large owner Reprogrammed Interchange Llc sold $1,703,971 worth of shares (984,805 units at $1.73), decreasing direct ownership by 3% to 33,228,487 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 271d
  Large owner Reprogrammed Interchange Llc sold $2,457,975 worth of shares (1,263,647 units at $1.95), decreasing direct ownership by 4% to 34,213,292 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 271d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 271d
  SEC Form 4 filed by Director Reed Sarah Burgess

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 276d
  Large owner Reprogrammed Interchange Llc sold $2,767,982 worth of shares (1,407,628 units at $1.97), decreasing direct ownership by 4% to 35,476,939 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 283d
  Large owner Reprogrammed Interchange Llc sold $2,848,511 worth of shares (1,417,998 units at $2.01), decreasing direct ownership by 4% to 36,884,567 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 285d
  Large owner Reprogrammed Interchange Llc sold $1,411,083 worth of shares (671,536 units at $2.10), decreasing direct ownership by 2% to 38,302,565 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 313d
  Chief Development Officer Zuraw Qing Che was granted 937,080 shares (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 325d
  SEC Form 4 filed by Director Detheux Michel

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 325d
  SEC Form 4 filed by Director Cumbo Alexander

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 333d
  CFO Mahatme Sandesh was granted 13,882,750 shares (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 346d
  SEC Form 4 filed by CEO and Chairman Kress Jean-Paul

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 381d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 381d
  SEC Form 4 filed by Director Resnick Joshua

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 381d
  SEC Form 4 filed by Director Lundberg Sven Ante

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 381d
  SEC Form 4 filed by Director Kalir Erez

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 381d
  SEC Form 4 filed by Director Beckman Daniella

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 381d
  SEC Form 4 filed by Director Namouni Fouad

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 381d
  SEC Form 4 filed by Director Lubner David Charles

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 381d
  SEC Form 4 filed by Director Patterson Matthew R

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 397d
  PRESIDENT AND CEO Ang Robert covered exercise/tax liability with 2,361 shares, decreasing direct ownership by 0.26% to 911,318 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 397d
  Chief Sci Off & Head Tech Ops Chakraborty Tirtha covered exercise/tax liability with 876 shares, decreasing direct ownership by 0.40% to 217,416 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 402d
  Chief Financial Officer Choi Han Wook covered exercise/tax liability with 2,061 shares, decreasing direct ownership by 4% to 51,280 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 402d
  Chief Sci Off & Head Tech Ops Chakraborty Tirtha covered exercise/tax liability with 1,947 shares, decreasing direct ownership by 0.88% to 218,292 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 402d
  PRESIDENT AND CEO Ang Robert covered exercise/tax liability with 5,273 shares, decreasing direct ownership by 0.57% to 913,679 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 475d
  CHIEF MEDICAL OFFICER Attar Eyal C. sold $3,162 worth of shares (2,227 units at $1.42), decreasing direct ownership by 2% to 126,625 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 481d
  CHIEF MEDICAL OFFICER Attar Eyal C. sold $3,499 worth of shares (2,554 units at $1.37), decreasing direct ownership by 2% to 128,852 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 486d
  CHIEF SCIENTIFIC OFFICER Chakraborty Tirtha covered exercise/tax liability with 1,033 shares, decreasing direct ownership by 0.47% to 220,239 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 486d
  PRESIDENT AND CEO Ang Robert covered exercise/tax liability with 2,787 shares, decreasing direct ownership by 0.30% to 918,952 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 486d
  CHIEF MEDICAL OFFICER Attar Eyal C. covered exercise/tax liability with 1,180 shares, decreasing direct ownership by 0.89% to 131,406 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 488d
  PRESIDENT AND CEO Ang Robert covered exercise/tax liability with 3,248 shares and was granted 137,500 shares, increasing direct ownership by 17% to 921,739 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 488d
  CHIEF SCIENTIFIC OFFICER Chakraborty Tirtha covered exercise/tax liability with 1,163 shares and was granted 52,500 shares, increasing direct ownership by 30% to 221,272 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 488d
  CHIEF MEDICAL OFFICER Attar Eyal C. covered exercise/tax liability with 1,353 shares and was granted 52,500 shares, increasing direct ownership by 63% to 132,586 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 488d
  Chief Financial Officer Choi Han Wook was granted 52,500 shares (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 516d
  SEC Form 4 filed by Director Kalir Erez

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 524d
  CHIEF MEDICAL OFFICER Attar Eyal C. sold $12,918 worth of shares (10,334 units at $1.25), decreasing direct ownership by 11% to 81,439 units (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)
• 525d
  Director Ra Capital Management, L.P. was granted 16,897,159 shares (SEC Form 4)

  4 - Vor Biopharma Inc. (0001817229) (Issuer)

Other VOR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends